<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03631030</url>
  </required_header>
  <id_info>
    <org_study_id>105-17-0004</org_study_id>
    <nct_id>NCT03631030</nct_id>
  </id_info>
  <brief_title>Cooled RF Lesion MRI Characteristics</brief_title>
  <official_title>A Prospective, Single-center, Pilot Study of in Vivo Lesion Characteristics Post Coolief Cooled Radiofrequency Denervation as a Treatment for Chronic Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>International Spine, Pain and Performance Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Halyard Health</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>International Spine, Pain and Performance Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This Prospective, Single-center, Pilot Study will assist in gaining an understanding of the
      actual CRFA lesions in an in vivo situation in areas where CRFA is utilized as a standard of
      care treatment option for the relief of chronic pain (cervical facet joints, thoracic facet
      joints, lumbar facet joints, Sacroiliac (SI) region, hip and knee).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be a prospective, single-center, pilot study. Adult subjects over the age 21
      diagnosed with chronic joint pain (≥ 3 months), scheduled to receive Radiofrequency
      denervation and meet the selection criteria are eligible to participate in this study. The
      specific targeted areas of interest in this study will include Cervical facet joints,
      Thoracic facet joints, Lumbar facet joints, Sacroiliac (SI) region, hip and knee.

      The treating physician will follow Standard of Care treatment for all enrolled subjects. As
      illustrated in Figure 1, the study consists of a screening visit, a treatment visit and a
      follow up visit. All subjects receiving CRFA will receive an MRI 2 - 7 days after the CRFA
      procedure. Subjects receiving CRFA of the Sacroiliac Joint will also receive an MRI within 30
      days prior to the CRFA procedure. The treating physician may also request an MRI be performed
      prior to the procedure for subjects receiving CRFA of other targeted areas. The point of
      enrollment for each subject is the time that they sign the Informed Consent Form.

      MRI data will be reviewed by the radiologist on a per patient basis to confirm lesion
      characteristics. It is anticipated that 3-5 subjects per level will be needed to fully
      quantify lesion characteristics, however; enrollment will remain flexible for each targeted
      area based on real time review of MRI data.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 25, 2018</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Prospective, singe group cohort study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cooled radiofrequency ablation lesion size</measure>
    <time_frame>MRI obtained between 2-7 days post-procedure.</time_frame>
    <description>Size in millimeters of cooled radiofrequency ablation lesion via MRI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain relief</measure>
    <time_frame>2-4 weeks post-procedure as compared to pre-procedure</time_frame>
    <description>Compare pre-procedure and post-procedure change in pain using the numerical pain rating scale with 0 being no pain and 10 being the worst possible pain.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Arthritis;Lumbosacral</condition>
  <condition>Osteo Arthritis Knee</condition>
  <condition>Sacroiliitis</condition>
  <condition>Hip Osteoarthritis</condition>
  <condition>Arthritis, Degenerative</condition>
  <arm_group>
    <arm_group_label>Cooled radiofrequency ablation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This is a single arm study. Patients who will be undergoing cooled radiofrequency ablation for the treatment of arthritis in the cervical facet joints, thoracic facet joints, lumbar facet joints, sacroiliac (SI) region, hip and knee.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cooled radiofrequency ablation</intervention_name>
    <description>Cooled Radiofrequency ablation (CRFA) is a well-established method for delivering lesions into nervous tissue to accomplish neurotomy procedures</description>
    <arm_group_label>Cooled radiofrequency ablation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age ≥ 21 years

          2. Able to understand the informed consent form and provide written informed consent and
             able to complete outcome measures.

          3. Must be clinically appropriate candidate to receive CRFA for treatment of chronic
             pain.

          4. Willing and able to receive an MRI

        Exclusion Criteria:

          1. Unable to receive an MRI (i.e. due to pacemaker or iron-based metal implant).

          2. Unable to receive an MRI (i.e. iron-based metal implant).

          3. Extremely thin patients and those with minimal subcutaneous tissue thickness that
             would not accommodate a radiofrequency lesion of up to 14mm in diameter to limit the
             risk of skin burns.

          4. Active joint infection or systemic or localized infection at the needle entry site
             (subject may be considered for inclusion once infection is resolved.)

          5. Subject currently implanted with a pacemaker or defibrillator

          6. In the event a pre-treatment MRI is obtained; trauma or injury occurring to the
             targeted area between the baseline MRI and CRFA treatment

          7. Subject unwillingness or unable to comply with protocol requirements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mehul Desai, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>International Spine Pain &amp; Performance Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>International Spine, and Performance Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>International Spine, Pain and Performance Center</name>
      <address>
        <city>Arlington</city>
        <state>Virginia</state>
        <zip>22205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Kapural L, Stojanovic M, Sessler DI, Bensitel T, Zovkic P. Cooled radiofrequency (RF) of L5 dorsal ramus for RF denervation of the sacroiliac joint: technical report. Pain Med. 2010 Jan;11(1):53-7. doi: 10.1111/j.1526-4637.2009.00772.x. Epub 2009 Dec 16. Erratum in: Pain Med. 2010 Dec;11(12):1874. Sessler, Daniel I [added].</citation>
    <PMID>20030745</PMID>
  </reference>
  <reference>
    <citation>Patel N, Gross A, Brown L, Gekht G. A randomized, placebo-controlled study to assess the efficacy of lateral branch neurotomy for chronic sacroiliac joint pain. Pain Med. 2012 Mar;13(3):383-98. doi: 10.1111/j.1526-4637.2012.01328.x. Epub 2012 Feb 2.</citation>
    <PMID>22299761</PMID>
  </reference>
  <reference>
    <citation>Stelzer W, Aiglesberger M, Stelzer D, Stelzer V. Use of cooled radiofrequency lateral branch neurotomy for the treatment of sacroiliac joint-mediated low back pain: a large case series. Pain Med. 2013 Jan;14(1):29-35. doi: 10.1111/pme.12014. Epub 2012 Dec 28.</citation>
    <PMID>23279364</PMID>
  </reference>
  <reference>
    <citation>Ho KY, Hadi MA, Pasutharnchat K, Tan KH. Cooled radiofrequency denervation for treatment of sacroiliac joint pain: two-year results from 20 cases. J Pain Res. 2013 Jul 4;6:505-11. doi: 10.2147/JPR.S46827. Print 2013.</citation>
    <PMID>23869175</PMID>
  </reference>
  <reference>
    <citation>Kapural L, Mekhail N. Novel intradiscal biacuplasty (IDB) for the treatment of lumbar discogenic pain. Pain Pract. 2007 Jun;7(2):130-4.</citation>
    <PMID>17559482</PMID>
  </reference>
  <reference>
    <citation>Karaman H, Tüfek A, Kavak GÖ, Kaya S, Yildirim ZB, Uysal E, Celik F. 6-month results of TransDiscal Biacuplasty on patients with discogenic low back pain: preliminary findings. Int J Med Sci. 2010 Dec 14;8(1):1-8.</citation>
    <PMID>21197258</PMID>
  </reference>
  <reference>
    <citation>Kapural L, Vrooman B, Sarwar S, Krizanac-Bengez L, Rauck R, Gilmore C, North J, Girgis G, Mekhail N. A randomized, placebo-controlled trial of transdiscal radiofrequency, biacuplasty for treatment of discogenic lower back pain. Pain Med. 2013 Mar;14(3):362-73. doi: 10.1111/pme.12023. Epub 2012 Dec 28.</citation>
    <PMID>23279658</PMID>
  </reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>March 5, 2018</study_first_submitted>
  <study_first_submitted_qc>August 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2018</study_first_posted>
  <last_update_submitted>August 6, 2019</last_update_submitted>
  <last_update_submitted_qc>August 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cooled radiofrequency ablation</keyword>
  <keyword>MRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Hip</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
    <mesh_term>Sacroiliitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 24, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/30/NCT03631030/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 12, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/30/NCT03631030/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

